Terminated PHASE4 INTERVENTIONAL 1-arm NCT01865253

Renal Denervation for Complicated Hypertension (RDNP-2012-03)

Sponsor: Baker Heart and Diabetes Institute

Updated 7 times since 2017 Last updated: Nov 1, 2018 Started: May 31, 2012 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No new participants enrolled. Protocol superseded.

Other terminated trials from Baker Heart and Diabetes Institute

See all terminations from Baker Heart and Diabetes Institute

Other Hypertension trials with similar outcome

Browse all Hypertension trials

This PHASE4 trial investigates Hypertension and is currently terminated or withdrawn. Baker Heart and Diabetes Institute leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE4
Dec 2018 — Nov 2020 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Jun 2018 — Dec 2018 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baker Heart and Diabetes Institute

Data source: Baker Heart and Diabetes Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia